3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Refractory or Relapsed Solid Tumors
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lymphoma, Follicular
1
Leukemia, Myeloid, Acute
1
Leukemia, Biphenotypic, Acute
1
Leukemia
1
Lethal Congenital Contracture Syndrome 2
1
Hematologic Neoplasms
1
Fallopian Tube Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Barrett Esophagus
1
Advanced Breast Cancer
1
Adenocarcinoma Of Esophagus
1
Interventions
Gemcitabine
7
Cisplatin
7
durvalumab
4
Oxaliplatin
3
Irinotecan
3
Folfox protocol
3
Bevacizumab
3
zanidatamab
2
pembrolizumab
2
Fluorouracil
2
Capecitabine
2
tremelimumab
1
trastuzumab deruxtecan
1
toripalimab
1
poly ICLC
1
niraparib
1
neratinib
1
ivosidenib
1
futibatinib
1
fludarabine
1
envafolimab
1
encorafenib
1
brigimadlin
1
binimetinib
1
Trastuzumab
1
Peptides
1
Pemetrexed
1
Paclitaxel
1
Nivolumab
1
Leucovorin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Biliary Tract Neoplasms
×
Itraconazole
×
30 days
×
Clear all
No trials found.